CN111773199A
|
|
Novel fluorocalcitriol preparation and preparation method thereof
|
CN111821275A
|
|
Fluorocalcitriol controlled release tablet
|
CN111840238A
|
|
Fluorocalcitriol tablet and preparation method thereof
|
CN111707766A
|
|
Detection method of furotriptan succinate tablet
|
CN111773197A
|
|
Novel alfacalcidol soft capsule and preparation method thereof
|
CN111686091A
|
|
Novel paricalcitol soft capsule and preparation method thereof
|
CN111707764A
|
|
Detection method of cyclobenzaprine hydrochloride sustained-release capsule
|
CN111773198A
|
|
Novel soft capsule of eldecalcitol and preparation method thereof
|
CN111707765A
|
|
Topiroxostat tablet detection method
|
CN111773196A
|
|
Novel calcitriol soft capsule and preparation method thereof
|
CN111544414A
|
|
Parlcidol capsule and preparation method thereof
|
CN111494336A
|
|
Cyclobenzaprine capsule
|
CN111544418A
|
|
Parlcidol capsule
|
CN111544406A
|
|
Parricalcitol oral preparation
|
CN111494329A
|
|
Cyclobenzaprine sustained release preparation
|
CN111494335A
|
|
Parricalcitol enteric-coated particle
|
CN111568873A
|
|
Cyclobenzaprine solid oral preparation and preparation method thereof
|
CN111437266A
|
|
Parlcidol sustained release granules
|
CN111544417A
|
|
Cyclobenzaprine sustained-release granules
|
CN111467325A
|
|
Cyclobenzaprine sustained-release capsule
|